Delivery Order SPE2DR25D2006-SPE2DR26F56FK
- Not listed
- The Defense Logistics Agency awarded a $1,498.08 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Ceftriaxone 1 GM-D5W bags, with completion scheduled for June 2, 2025. This competitively awarded, firm fixed-price contract requires performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, a commonly used broad-spectrum antibiotic. The contract, valued at $5,210.50 with a firm fixed-price structure, is scheduled for completion by June 20, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ceftriaxone 1 GM-D5W bags, with a contract value of $4,118.65. This delivery order represents a firm fixed price procurement with an ultimate completion date of September 18, 2025, and utilizes no set-aside provisions, indicating competitive award procedures. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, a broad-spectrum antibiotic commonly used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $5,353.10, is scheduled for completion by August 14, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $2,871.80 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 2 GM-D5W bags, a broad-spectrum antibiotic commonly used in military and federal healthcare settings. Awarded on November 5, 2025, with completion targeted for November 6, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement under a competitive, non-set-aside award. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a $1,927.02 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a $3,080.22 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ceftriaxone 1 GM-D5W bags, with an ultimate completion date of November 4, 2025. This non-set-aside contract was awarded on November 3, 2025, and represents a routine pharmaceutical procurement fulfilling federal medical supply requirements. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $11,342.44 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 1 GM-D5W bags, a broad-spectrum antibiotic commonly used in military and federal healthcare systems. This firm fixed-price delivery order, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a non-competitive set-aside award. The product will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,328.85 to supply Ceftriaxone 1 GM-D5W bags, an antibiotic medication commonly used in military and federal healthcare systems. This non-competitive delivery order was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, under a firm fixed price arrangement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $11,794.85 to AmerisourceBergen Drug Corp for Ceftriaxone 2 GM-D5W bags, with an ultimate completion date of September 8, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively on September 5, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F56FKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Ceftriaxone 1 GM-D5W bags, with a ceiling value of $1,303.03 under a firm fixed-price arrangement. The delivery order carries an ultimate completion date of November 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, consistent with the company's track record of winning federal contracts through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally. The award of this antibiotic supply delivery order demonstrates the company's continued role in fulfilling essential pharmaceutical requirements for Defense Department medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/20/25 |